Today Macanda is excited to welcome Marcus Hultberg, Jonas Lindblom and Emma Medin as new partners! Together we are establishing a Nordic market access consultancy for clients with therapies where experience makes a difference.
Emma, Jonas and Marcus hold extensive experience from consulting, medical, commercial, payer and academic roles, and from having supported clients in the Nordics with tailored market access solutions over the past decade. They have developed unique expertise in the field of access for advanced therapies (ATMPs) and orphan drugs in rare diseases and oncology.
Welcome to the team!